Marijuana Company of America (MCOA) 10-Q 20 May 19 2019 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 20, 2019
Document And Entity Information
Entity Registrant Name	Marijuana Co of America, Inc.
Entity Central Index Key	0001078799
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	Yes
Is Entity Emerging Growth Company?	true
Elected Not To Use the Extended Transition Period	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Common Stock, Shares Outstanding		2,810,345,150
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2019

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash	$ 509,462	$ 359,577
Short-term Investments	675,000	810,000
Accounts receivable, net	77,494	46,376
Inventory	231,666	186,989
Other current assets	156,424	93,833
Total current assets	1,650,046	1,496,775
Property and equipment, net	13,066	12,430
Other assets:
Investments	477,576	408,077
Security deposit	2,500	2,500
Total assets	2,143,188	1,919,782
Current liabilities:
Accounts payable	433,450	416,444
Accrued compensation	442,659	454,316
Accrued liabilities	187,991	216,946
Debt obligation of Joint venture	128,522	289,742
Notes payable, related party	396,781	287,140
Convertible notes payable, net of debt discount of1,391,618 and $896,180, respectively	1,536,271	1,132,669
Derivative liability	4,961,666	2,256,631
Total current liabilities	8,087,340	5,053,887
Total liabilities	8,087,340	5,053,887
Stockholders' deficit:
Preferred stock, $0.001 par value, 50,000,000 shares authorized; Class A preferred stock, $0.001 par value, 10,000,000 shares designated, 10,000,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018	10,000	10,000
Common stock, $0.001 par value; 5,000,000,000 shares authorized; 2,687,790,776 and 2,561,238,082 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively	2,687,791	2,561,238
Common stock subscriptions		90,000
Additional paid in capital	49,574,330	48,188,522
Accumulated deficit	(58,216,272)	(53,983,895)
Total stockholders' deficit	(5,944,151)	(3,134,105)
Total liabilities and stockholders' deficit	2,143,188	1,919,782
Class A Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, $0.001 par value, 50,000,000 shares authorized; Class A preferred stock, $0.001 par value, 10,000,000 shares designated, 10,000,000 shares issued and outstanding as of March 31, 2019 and December 31, 2018	10,000	10,000
Total stockholders' deficit	10,000	10,000
Total liabilities and stockholders' deficit	$ 10,000	$ 10,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Convertible note payable, net of debt discount - current	$ 1,391,618	$ 896,180
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	5,000,000,000	5,000,000,000
Common stock, shares issued	2,687,790,776	2,561,238,082
Common stock, shares outstanding	2,687,790,776	2,561,238,082
Class A Preferred Stock [Member]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	10,000,000	10,000,000
Preferred stock, shares outstanding	10,000,000	10,000,000

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
REVENUES:
Sales	$ 113,271	$ 19,010
Related party Sales	1,539
Total Revenues	114,810	19,010
Cost of sales	39,878	10,446
Gross Profit	74,932	8,564
OPERATING EXPENSES:
Selling, general and administrative expenses	987,341	301,479
Depreciation	1,696	1,393
Total operating expenses	989,037	302,872
Net loss from operations	(914,105)	(294,308)
OTHER INCOME (EXPENSES):
Interest expense, net	436,282	730,746
Impairment of Joint Ventures	12,000
Loss on equity investments	(47,541)	(37,673)
(Loss) gain on change in fair value of derivative liabilities	(2,687,449)	5,056,686
Unrealized loss on trading securities	(135,000)
Gain on settlement of debt		156,389
Total other income (expense)	(3,318,272)	4,445,106
(Loss) income before income taxes	(4,232,377)	4,150,798
Income taxes (benefit)
NET INCOME (LOSS)	$ (4,232,377)	$ 4,150,798
Income (loss) per common share, basic	$ (0.002)	$ 0.002
Weighted average number of common shares outstanding, basic and diluted	2,326,751,396	2,122,103,506

Condensed Consolidated Statem_2

Condensed Consolidated Statement Of Stockholders' Deficit - USD ($)	Class A Preferred Stock [Member]	Common Stock [Member]	Common Stock Subscriptions [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance preferred stock, shares at Dec. 31, 2017	10,000,000
Balance common stock, shares at Dec. 31, 2017		2,103,464,006
Balance, value at Dec. 31, 2017	$ 10,000	$ 2,103,464		$ 30,456,888	$ (42,888,104)	$ (10,317,752)
Common stock issued for services rendered, shares		1,000,000
Common stock issued for services rendered, value		$ 1,000		51,100		52,100
Common stock issued in settlement of convertible notes payable, shares		16,637,073
Common stock issued in settlement of convertible notes payable, value		$ 16,637		366,015		382,652
Common stock issued in exchange for exercise of warrants on a cashless basis, shares		18,206,796
Common stock issued in exchange for exercise of warrants on a cashless basis, value		$ 18,207		(18,207)
Reclassification of derivative liabilities				627,439		627,439
Reclassification of warrant liability				691,850		691,850
Stock based compensation				(364,499)		(364,499)
Net income (loss)					4,150,799	4,150,798
Balance preferred stock , shares at Mar. 31, 2018	10,000,000
Balance common stock, shares at Mar. 31, 2018		2,139,307,875
Balance, value at Mar. 31, 2018	$ 10,000	$ 2,139,308		31,810,586	(38,737,305)	$ (4,777,412)
Balance preferred stock, shares at Dec. 31, 2018	10,000,000
Balance common stock, shares at Dec. 31, 2018		2,561,238,082				2,561,238,082
Balance, value at Dec. 31, 2018	$ 10,000	$ 2,561,238	$ 90,000	481,488,552	(53,983,895)	$ (3,134,105)
Common stock issued for services rendered, shares		8,500,000
Common stock issued for services rendered, value		$ 8,500		143,350		153,850
Common stock issued in exchange for exercise of warrants on a cashless basis, shares		39,333,332
Common stock issued in exchange for exercise of warrants on a cashless basis, value		$ 39,333	(40,000)	40,667		40,000
Common stock issued in settlement of convertible notes payable and accrued interest, shares		54,819,089
Common stock issued in settlement of convertible notes payable and accrued interest, value		$ 54,820		581,892		636,712
Additional paid-in capital due to issuance of convertible debt				462,714		462,714
Sale of common stock, shares		23,900,273
Sale of common stock, value		$ 23,900	(50,000)	155,155		129,055
Net income (loss)					(4,232,377)	$ (4,232,377)
Balance preferred stock , shares at Mar. 31, 2019	10,000,000
Balance common stock, shares at Mar. 31, 2019		2,687,790,776				2,687,790,776
Balance, value at Mar. 31, 2019	$ 10,000	$ 2,687,791		$ 49,574,330	$ (58,216,272)	$ (5,944,151)

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (4,232,377)	$ 4,150,798
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,696	1,393
Amortization of debt discount	495,438	502,682
Non cash interest	436,282	187,861
Unrealized loss on trading securities	(135,000)
Loss (Gain) on change in fair value of derivative liabilities	(2,687,449)	5,056,686
Impairment of investment in BV joint venture	12,000
Stock based compensation	254,200	(312,400)
Gain on settlement of debt		156,839
Loss on equity investment	(47,541)	(37,673)
Changes in operating assets and liabilities:
Accounts receivable	31,118	(1,149)
Inventory	44,677	(65,210)
Other current assets	62,591
Accounts payable	69,278	17,329
Accrued liabilities	36,438
Accrued compensation	(11,657)	195,000
Net cash used in operating activities	(207,098)	(497,250)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of investments	290,260
Purchase of property and equipment	2,332	4,202
Net cash used in investing activities	(292,592)	(4,202)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable	649,575	400,000
Proceeds from issuance of notes payable, related party		21,706
Proceeds from sale of common stock
Net cash provided by financing activities	649,575	421,706
Net increase (decrease) in cash	149,885	(79,746)
Cash-beginning of period	359,577	249,831
Cash-end of period	509,462	170,085
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid
Taxes paid
Non cash financing activities:
Common stock issued in settlement of convertible notes payable	$ 462,714	$ 382,652

Nature Of Operations And Basis

Nature Of Operations And Basis Of Presentation	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature Of Operations And Basis Of Presentation	NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION Marijuana Company of America, Inc. (the “Company”) was incorporated under the laws of the State of Utah in October 1985 under the name Mormon Mint, Inc. The corporation was originally a startup company organized to manufacture and market commemorative medallions related to the Church of Jesus Christ of Latter Day Saints. On January 5, 1999, Bekam Investments, Ltd. acquired one hundred percent of the common shares of the Company and spun the Company off changing its name Converge Global, Inc. From August 13, 1999 until November 20, 2002, the Company focused on the development and implementation of Internet web content and e-commerce applications. In October 2009, in a 30 for 1 exchange, the Company merged with Sparrowtech, Inc. for the purpose of exploration and development of commercially viable mining properties. From 2009 to 2014, we operated primarily in the mining exploration business. In 2015, the Company changed its business model to a marketing and distribution company for medical marijuana. In conjunction with the change, the Company changed its name to Marijuana Company of America, Inc. At the time of the transition in 2015, there were no remaining assets, liabilities or operating activities of the mining business. On September 21, 2015, the Company formed H Smart, Inc., a Delaware corporation as a wholly owned subsidiary for the purpose of operating the hempSMART™ brand. On February 1, 2016, the Company formed MCOA CA, Inc., a California corporation as a wholly owned subsidiary to facilitate mergers, acquisitions and the offering of investments or loans to the Company. On May 3, 2017, the Company formed Hempsmart Limited, a United Kingdom corporation as a wholly owned subsidiary for the purpose of future expansion into the European market. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: H Smart, Inc., Hempsmart Limited and MCOA CA, Inc. All significant intercompany balances and transactions have been eliminated in consolidation. The condensed balance sheet as of December 31, 2018 has been derived from audited financial statements. Operating results for the three months ended March 31, 2019 are not necessarily indicative of results that may be expected for the year ending December 31, 2019. These condensed financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2018.

Going Concern And Management's

Going Concern And Management's Liquidity Plans	3 Months Ended
	Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern and Management's Liquidity Plans	NOTE 2 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the accompanying financial statements during three months ended March 31, 2019, the Company incurred net losses from operations of $4,232,377 and used cash in operations of $207,098. These factors among others may indicate that the Company will be unable to continue as a going concern for a reasonable period of time. The Company's primary source of operating funds for the three months ended March 31, 2019 has been from revenue generated from proceeds from the issuance of convertible and other debt. The Company has experienced net losses from operations since inception, but expects these conditions to improve in 2019 and beyond as it develops its business model. The Company has stockholders' deficiencies at March 31, 2019 and requires additional financing to fund future operations. The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Summary Of Significant Accounting Policies	NOTE 3 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Interim Financial Statements The unaudited condensed interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Revenue Recognition The Company recognizes revenue when: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related revenue is recorded. The Company defers any revenue for which the services has not been performed or is subject to refund until such time that the Company and the customer jointly determine that the services has been performed or no refund will be required. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates. Cash The Company considers cash to consist of cash on hand and temporary investments having an original maturity of 90 days or less that are readily convertible into cash. Concentrations of credit risk The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Occasionally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management. Accounts Receivable Trade receivables are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term basis; thus, trade receivables do not bear interest. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition. Allowance for Doubtful Accounts Any charges to the allowance for doubtful accounts on accounts receivable are charged to operations in amounts sufficient to maintain the allowance for uncollectible accounts at a level management believes is adequate to cover any probable losses. Management determines the adequacy of the allowance based on historical write-off percentages and the current status of accounts receivable. Accounts receivable are charged off against the allowance when collectability is determined to be permanently impaired. As of March 31, 2019, and December 31, 2018, allowance for doubtful accounts was $0 and $0, respectively. Inventories Inventories are stated at the lower of cost or market with cost being determined on a first-in, first-out (FIFO) basis. The Company writes down its inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. During the periods presented, there were no inventory write-downs. Cost of sales Cost of sales is comprised of cost of product sold, packaging, and shipping costs. Stock Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash. Earnings per Share Basic earnings per share are calculated by dividing net income (loss) by the weighted average number of shares of the Company’s common stock outstanding during the period. “Diluted earnings per share” reflects the potential dilution that could occur if our share-based awards and convertible securities were exercised or converted into common stock. The dilutive effect of our share-based awards is computed using the treasury stock method, which assumes all share-based awards are exercised and the hypothetical proceeds from exercise are used to purchase common stock at the average market price during the period. The incremental shares (difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted EPS calculation. The dilutive effect of our convertible preferred stock and convertible debentures is computed using the if-converted method, which assumes conversion at the beginning of the year. As of March 31, 2019, and 2018, respectively, common stock equivalents relating to convertible debt, warrants and options were not included in the denominators of the diluted earnings per share as their effect would be anti-dilutive. Property and Equipment Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 3 to 5 years. Investments The Company follows Accounting Standards Codification subtopic 321-10, Investments-Equity Securities (“ASC 321-10) which requires the accounting for equity security to be measured at fair value with changes in unrealized gains and losses are included in current period operations. Where an equity security is without a readily determinable fair value, the Company may elect to estimate its fair value at cost minus impairment plus or minus changes resulting from observable price changes (See Note 4). Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. The Company’s free-standing derivatives consisted of conversion options embedded within its issued convertible debt and warrants with anti-dilutive (reset) provisions. The Company evaluated these derivatives to assess their proper classification in the balance sheet using the applicable classification criteria enumerated under GAAP. The Company determined that certain conversion and exercise options do not contain fixed settlement provisions. The convertible notes contain a conversion feature and warrants have a reset provision such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the conversion feature and the reset provision which does not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus, any available shares are allocated first to contracts with the most recent inception dates. Fair Value of Financial Instruments Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2019 and December 31, 2018. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash and accounts payable. Fair values were assumed to approximate carrying values for cash, accounts payables and short term notes because they are short term in nature. Advertising The Company follows the policy of charging the costs of advertising to expense as incurred. The Company charged to operations $141,339 and $55,745 for the three months ended March 31, 2019 and 2018, respectively, as advertising costs. Income Taxes Deferred income tax assets and liabilities are determined based on the estimated future tax effects of net operating loss and credit carry forwards and temporary differences between the tax basis of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records an estimated valuation allowance on its deferred income tax assets if it is not more likely than not that these deferred income tax assets will be realized. The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of March 31, 2019, and 2018, the Company has not recorded any unrecognized tax benefits. Segment Information Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions how to allocate resources and assess performance. The information disclosed herein materially represents all of the financial information related to the Company's only material principal operating segment. Recent Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (ASU 2016-02). Under ASU No. 2016-2, an entity is required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. ASU No. 2016-02 offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. For public companies, The Company adopted this standard on January 1, 2019 using the modified retrospective method. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permitted the Company not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs; and all of the new standard’s available transition practical expedients. Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed.

Property And Equipment

Property And Equipment	3 Months Ended
	Mar. 31, 2019
Property, Plant and Equipment [Abstract]
Property and Equipment	NOTE 3 – PROPERTY AND EQUIPMENT Property and equipment as of March 31, 2019 and December 31, 2018 is summarized as follows: March 31, 2019 December 31, 2018 Computer equipment $ 17,438 $ 15,207 Furniture and fixtures 5,140 5,140 Subtotal 22,578 20,347 Less accumulated depreciation (9,512 ) (7,917 ) Property and equipment, net $ 13,066 $ 12,430 Property and equipment are stated at cost and depreciated using the straight-line method over their estimated useful lives of 3 years. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. Depreciation expense was $1,696 and $1,393 for the three months ended March 31, 2019 and 2018, respectively.

Investments

Investments	3 Months Ended
	Mar. 31, 2019
Investments, All Other Investments [Abstract]
Investments	NOTE 4 – INVESTMENTS MoneyTrac The Company accounts for its investment in MoneyTrac Technology, Inc. at estimated market fair value using the market price for the publicly traded shares under the ticker symbol “GOHE” as listed on OTC Markets as an indicator of fair market value. As of March 31, 2019, and December 31, 2018, the balance of this investment was 675,000 and $810,000, respectively and was classified as a short-term investment as of for both periods. . Benihemp Global Hemp Group JV Global Hemp Group Joint Venture/Scio Oregon Hemp Project On May 8, 2018, the Company, Global Hemp Group, Inc., a Canadian corporation, and TTO Enterprises, Ltd., an Oregon corporation entered into a Joint Venture Agreement. The purpose of the joint venture is to develop a project to commercialize the cultivation of industrial hemp on a 109 acre parcel of real property owned by the Company and Global Hemp Group in Scio, Oregon, and operating under the Oregon corporation Covered Bridges, Ltd. The joint venture is in the development stage. On May 30, 2018, the joint venture purchased TTO’s 15% interest in the joint venture for $30,000. The Company and Global Hemp Group, Inc. now have an equal 50-50 interest in the joint venture. The joint venture agreement commits the Company to a cash contribution of $600,000 payable on the following funding schedule: $200,000 upon execution of the joint venture agreement; $238,780 by July 31, 2018; $126,445 by October 31, 2018; and, $34,775 by January 31, 2019. The Company has complied with its payments. The 2018 crop of hemp grown on the joint venture’s real property consisted of 33 acres of high yielding CBD hemp grown in an orchard style cultivation on the property. The 2018 harvest consisted of approximately 37,000 high yielding CBD hemp plants producing 24 tons of biomass that produced 48,000 pounds of dried biomass. The joint venture partners prepared processing samples ranging in size from 100 lbs. to 2,000 lbs. for sample offers to extraction companies. The biomass is being processed into CBD crude oil with the option to refine it further into isolate, or full spectrum oil, in order to increase its value on the market. Results from the current extraction test batches are expected to be received by May 2019 and will serve as a basis for the final terms of the sale of the biomass by the Partners.

Notes Payable, Related Party

Notes Payable, Related Party	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Notes Payable, Related Party	NOTE 5 – NOTES PAYABLE, RELATED PARTY As of March 31, 2019, and December 31, 2018, the Company’s officers and directors have provided advances and incurred expenses on behalf of the Company. The issued notes are unsecured, due on demand and bear 5% interest .

Convertible Note Payable

Convertible Note Payable	3 Months Ended
	Mar. 31, 2019
Debt Disclosure [Abstract]
Convertible Note Payable	NOTE 6 – CONVERTIBLE NOTE PAYABLE Convertible notes payable are comprised of the following: March 31, 2019 December 31, 2018 Convertible note payable-John Fife, last due October 27, 2018 $ — $ 150,959 Convertible notes payable-St George-last due January 24, 2020 2,927,889 1,877,890 Total 2,927,889 2,028,849 Less debt discounts (1,391,618 ) (896,180 ) Net 1,536,271 1,132,669 Less current portion 1,536,271 (1,132,669 ) Long term portion $ — $ — Convertible notes payable-St George Investments Effective November 1, 2017, the Company issued a secured convertible promissory note in aggregate amount of $601,420 to St George Investments LLC (“St George”). The promissory note bears interest at 10% per annum, is due upon maturity sixteen months after the purchase price date and includes an original issue discount (“OID”) of $59,220. The promissory note was funded on November 11, 2017 of $542,200; net of OID and transaction costs. As of March 31, 2019, the Company owed $417,890 on this convertible promissory note. Effective December 20, 2017, the Company issued a secured convertible promissory note in aggregate of $1,655,000 to St George Investments LLC (“St George”). The promissory note bears interest at 10% per annum, is due upon maturity sixteen months after purchase price date and includes an original issue discount (“OID”) of $155,000. In addition, the Company agreed to pay $5,000 for legal, accounting and other transaction costs of the lender. The promissory note was funded in nine tranches of $300,000; $200,000; $200,000; $400,000; $75,000; $150,000; $85,000; $120,000 and $70,000, resulting in receiving aggregate net proceeds of $1,500,000. The Company had received aggregate net proceeds of $300,000 during the year ended December 31, 2017 with the remaining tranches received during the year ended December 31, 2018. As an investment incentive, the Company issued 66,000,000 5 year warrants, exercisable at $.04 with certain reset provisions. The promissory notes are convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price. The Company has a right to prepayment of the note, subject to a 20% prepayment premium and is secured by a trust deed of certain assets of the Company. During the three months ended March 31, 2019, $220,000 of principal along with $100,336 of derivative liabilities valued as of the respective conversion dates were converted into 31,151,515 shares of common stock. On November 5, 2018, $250,000 of principal and accrued interest was assigned to John Fife as an individual with all the terms and conditions of the original note issued to St George. On March 21, 2019, $150,959 of principal and $4,963 of accrued interest along with $160,454 of derivative liabilities valued as of the respective conversion date were converted into 23,667,574 shares of common stock. Effective August 28, 2018, the Company issued a secured convertible promissory note in aggregate of $1,105,000 to St George Investments LLC (“St George”). The promissory note bears interest at 10% per annum, is due upon maturity ten months after purchase price date and includes an original issue discount (“OID”) of $100,000. In addition, the Company agreed to pay $5,000 for legal, accounting and other transaction costs of the lender. During the year ended December 31, 2018, the promissory note was funded in seven tranches totaling aggregate net proceeds of $825,000. As an investment incentive, the Company issued 45,000,000 5 year warrants, exercisable at $.04 with certain reset provisions. The promissory note is convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price. The Company has a right to prepayment of the note, subject to a 15% prepayment premium and is secured by a trust deed of certain assets of the Company. During the three months ended March 31, 2019, an additional $135,000 was funded under this note for net proceeds of $125,000. The aggregate fair value of $1,588,493 of the issued warrants was allocated to this funding based on the funding’s percentage of the $1,105,000 face value. The determined fair value of warrants issued was then allocated between the debt instrument and warrants based on their relative fair values. The portion of the proceeds allocated to the warrants has been added to the debt discount, included in additional paid in capital and amortized over the life of the debt. At the funding date of the eight tranche of this note, the Company determined an aggregate fair value of the embedded derivatives on the total outstanding balance of this note of $1,180,646. The fair value of the embedded derivatives was determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 112.4%, (3) weighted average risk-free interest rate of 2.54%, (4) expected life of .481 years, and (5) estimated fair value of the Company's common stock from $.018 per share. The determined aggregate fair value of the debt derivatives was adjusted with a $36,343 reduction of interest expense during the three months ending March 31, 2019. Effective January 29, 2019, the Company issued a secured convertible promissory note in aggregate of $2,205,000 to St George Investments LLC (“St George”). The promissory note bears interest at 10% per annum, is due upon maturity ten months after the purchase price date and includes an original issue discount (“OID”) of $200,000. In addition, the Company agreed to pay $5,000 for legal, accounting and other transaction costs of the lender. During the three months ended March 31, 2019, the promissory note was funded in three tranches totaling $555,000 resulting in receiving aggregate net proceeds of $500,000 under this note. The net proceeds received consisted of $393,780 in cash and $161,220 in payments on behalf of the Company. As an investment incentive, the Company issued 90,000,000 5 year warrants, exercisable at $.04 with certain reset provisions. The promissory note is convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price. The Company has a right to prepayment of the note, subject to a 15% prepayment premium and is secured by a trust deed of certain assets of the Company. Additionally, at the date of issuance, the Company determined the aggregate fair value of the issued warrants at $999,838. The fair value of the warrants were determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 109.63%, (3) weighted average risk-free interest rate of 2.55%, (4) expected life of 5.00 years, and (5) estimated fair value of the Company's common stock of $0.0162 per share. The aggregate fair value of the issued warrants is allocated to each funding based on the funding’s percentage of the aggregate warrant face value. The determined fair value of warrants issued was then allocated between the debt instrument and warrants based on their relative fair values. The portion of the proceeds allocated to the warrants has been added to the debt discount, included in additional paid in capital and amortized over the life of the debt. During the three months ended March 31, 2019, the portion of proceeds allocated to warrants totaled $167,225. At the funding dates of the notes, the Company determined an aggregate fair value of $44,898 of the embedded derivatives. The fair value of the embedded derivatives was determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 107.91% to 109.79%, (3) weighted average risk-free interest rate of 2.31% to 2.50%, (4) expected life of .750 to .836 years, and (5) estimated fair value of the Company's common stock from $.0132 to $.0163 per share. The determined fair value of the debt derivatives was charged as a debt discount up to the net proceeds of the note. Effective March 25, 2019, the Company issued a secured convertible promissory note in aggregate of $580,000 to St George Investments LLC (“St George”). The promissory note bears interest at 10% per annum, is due upon maturity ten months after the purchase price date and includes an original issue discount (“OID”) of $75,000. In addition, the Company agreed to pay $5,000 for legal, accounting and other transaction costs of the lender. During the three months ended March 31, 2019, the promissory note was funded in the amount of $580,000 resulting in receiving aggregate net proceeds of $500,000 under this note. As an investment incentive, the Company issued 22,500,000 5 year warrants, exercisable at $.04 with certain reset provisions. The promissory note is convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price. The Company has a right to prepayment of the note, subject to a 15% prepayment premium and is secured by a trust deed of certain assets of the Company. Additionally, at the date of issuance, the Company determined the aggregate fair value of the issued warrants at $258,701. The fair value of the warrants were determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 108.20%, (3) weighted average risk-free interest rate of 2.21%, (4) expected life of 5.00 years, and (5) estimated fair value of the Company's common stock of $0.0169 per share. The determined fair value of warrants issued was allocated between the debt instrument and warrants based on their relative fair values. The portion of the proceeds allocated to the warrants has been added to the debt discount, included in additional paid in capital and amortized over the life of the debt. During the three months ended March 31, 2019, the portion of proceeds allocated to warrants totaled $170,489. At the funding dates of the notes, the Company determined an aggregate fair value of $233,477 of the embedded derivatives. The fair value of the embedded derivatives was determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 108.85%, (3) weighted average risk-free interest rate of 2.48%, (4) expected life of .836 years, and (5) estimated fair value of the Company's common stock from $.0169 per share. The determined fair value of the debt derivatives was charged as a debt discount up to the net proceeds of the note. Summary: The Company has identified the embedded derivatives related to the above described notes and warrants. These embedded derivatives included certain conversion and reset features. The accounting treatment of derivative financial instruments requires that the Company record fair value of the derivatives as of the inception date of the note and to fair value as of each subsequent reporting date. At March 31, 2019, the Company determined the aggregate fair values of $4,961,666 of embedded derivatives. The fair values were determined using the Binomial Option Pricing Model based on the following assumptions: (1) dividend yield of 0%; (2) expected volatility of 107.54%, (3) weighted average risk-free interest rate of 2.40%, (4) expected life of 0.250 to .817 years, and (5) estimated fair value of the Company's common stock from $0.0151 per share. For the three months ended March 31, 2019, the Company recorded a loss on change in fair value of derivative liabilities of $2,687,449 and recorded amortization of debt discounts of $463,282 as a charge to interest expense, respectively.

Stockholders' Deficit

Stockholders' Deficit	3 Months Ended
	Mar. 31, 2019
Stockholders Deficit
Stockholders' Deficit	NOTE 7 – STOCKHOLDERS’ DEFICIT Preferred stock The Company is authorized to issue 50,000,000 shares of $0.001 par value preferred stock as of March 31, 2019 and December 31, 2018. As of March 31, 2019, and December 31, 2018, the Company has designated and issued 10,000,000 shares of Class A Preferred Stock. Each share of Class A Preferred Stock is entitled to 100 votes on all matters submitted to a vote to the stockholders of the Company, does not have conversion, dividend or distribution upon liquidation rights. Common stock The Company is authorized to issue 5,000,000,000 shares of $0.001 par value common stock as of March 31, 2019 and December 31, 2018. As of March 31, 2019, and December 31, 2018, the Company had 2,687,790,776 and 2,561,238,082, respectively, common shares issued and outstanding. During the three months ended March 31, 2019, the Company issued an aggregate of 8,500,000 shares of its common stock for services rendered with an estimated fair value of $153,850. During the three months ended March 31, 2019, the Company issued 54,819,089 shares of its common stock in settlement of convertible notes payable, accrued interest and embedded derivative liabilities of $636,712. During the three months ended March 31, 2019, the company issued 39,333,332 shares of its common stock in exchange for exercise of warrants on a cashless basis. During the three months ended March 31, 2019, the Company sold an aggregate of 23,900,273 shares of its common stock for net proceeds of $129,055. Options The following table summarizes the stock option activity for the three months ended March 31, 2019: Shares Weighted-Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2018 1,000,000,000 $ 0.005 6.76 $ 10,100,000 Granted — — — — Cancellations (1,000,000,000 ) 0.005 6.76 — Forfeitures or expirations — — — — Outstanding at March 31, 2019 — $ — — $ — Exercisable at March 31, 2019 — $ — — $ — On February 27, 2019, Donald Steinberg and Charles Larsen canceled all 1,000,000,000 stock options previously issued to them by the Company. The following table presents information related to stock options at March 31, 2019: Options Outstanding Options Exercisable Exercise Price Number of Options Weighted Average Remaining Life In Years Exercisable Number of Options $ — — — — Warrants The following table summarizes the stock warrant activity for the three months ended March 31, 2019: Shares Weighted-Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2019 110,846,817 $ 0.039 4.18 $ 25,500 Granted 115,166,666 0.020 4.87 267 Exercised (11,551,252 ) 0.020 2.55 20,400 Outstanding at March 31, 2019 214,462,231 $ 0.040 4.44 $ 5,367 Exercisable at March 31, 2019 214,462,231 $ 0.040 4.44 $ 5,367 The aggregate intrinsic value in the preceding tables represents the total pretax intrinsic value, based on options with an exercise price less than the Company’s stock price of as of March 31, 2019, which would have been received by the option holders had those option holders exercised their options as of that date. The following table presents information related to warrants at March 31, 2019: Warrants Outstanding Warrants Exercisable Exercise Price Number of Warrants Weighted Average Remaining Life In Years Exercisable Number of Warrants $ 0.04 214,462,231 4.44 214,462,231 In connection with the issuance of convertible notes payable, the Company issued an aggregate of 112,500,000 warrants to purchase the Company’s common stock at $0.04 per share, vesting immediately and expiring 5 years from the date of issuance. (See Note 6) Restricted Stock Units (“RSU”) The following table summarizes the restricted stock activity for the three months ended March 31, 2019: Total Restricted Shares Issued at January 1, 2019 10,000,000 Granted — Forfeited — Total Restricted Shares Issued at March 31, 2019 10,000,000 Vested at March 31, 2019 10,000,000

Fair Value Measurement

Fair Value Measurement	3 Months Ended
	Mar. 31, 2019
Fair Value Disclosures [Abstract]
Fair Value Measurement	NOTE 8 — FAIR VALUE MEASUREMENT The Company adopted the provisions of Accounting Standards Codification subtopic 825-10, Financial Instruments (“ASC 825-10”) on January 1, 2008. ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value: Level 1 – Quoted prices in active markets for identical assets or liabilities. Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 – Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities. All items required to be recorded or measured on a recurring basis are based upon level 3 inputs. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement. Upon adoption of ASC 825-10, there was no cumulative effect adjustment to beginning retained earnings and no impact on the financial statements. The carrying value of the Company’s cash and cash equivalents, accounts receivable, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity. As of March 31, 2019, and December 31, 2018, the Company did not have any items that would be classified as level 1 or 2 disclosures. The Company recognizes its derivative liabilities as level 3 and values its derivatives using the methods discussed in note 6. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed in Note 6 are that of volatility and market price of the underlying common stock of the Company. As of March 31, 2019, and December 31, 2018, the Company did not have any derivative instruments that were designated as hedges. The derivative liability as of March 31, 2019 and December 31, 2018, in the amount of $4,961,666 and $2,256,631, respectively, have a level 3 classification. The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the three years ended March 31, 2019: Debt Derivative Balance, January 1, 2019 $ 2,256,631 Total (gains) losses Initial fair value of debt derivative at note issuance 278,376 Mark-to-market at March 31, 2019: 2,687,449 Transfers out of Level 3 upon conversion or payoff of notes payable (260,790 ) Balance, March 31, 2019 $ 4,961,666 Net gain for the period included in earnings relating to the liabilities held during the period ended March 31, 2019 $ 2,723,792 Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. During the period ended March 31, 2019, the Company’s stock price decreased significantly from initial valuations. As the stock price decreases for each of the related derivative instruments, the value to the holder of the instrument generally decreases. Stock price is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2019
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 9 — RELATED PARTY TRANSACTIONS The Company’s current officers and stockholders advanced funds to the Company for travel related and working capital purposes. As of March 31, 2019, and December 31, 2018, there were no related party advances outstanding. As of March 31, 2019, and December 31, 2018, accrued compensation due officers and executives included as accrued compensation was $442,659 and $454,316, respectively. At March 31, 2019 and December 31, 2018, there were an aggregate of $396,781 and $287,140 notes payable due to officers. The notes are at 5% per annum and non-interest bearing, respectively, and are due on demand.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2019
Subsequent Events [Abstract]
Subsequent Events	NOTE 11 – SUBSEQUENT EVENTS On April 15, 2019, the Company entered into a material definitive agreement with Natural Plant Extract of California, Inc., a California corporation to form a joint venture incorporated in California under the name “Viva Buds, Inc.” for the purpose of operating a California based licensed cannabis distribution business pursuant to California law legalizing cannabis for recreational and medicinal use; the Company filed Form 8-K on April 15, 2019. On April 24, 2019, the Company appointed Edward Manolos as an independent director; the Company filed Form 8-K on April 24, 2019. On May 1, 2019, the Company entered into a material definitive agreement with Unicast Equities, LLC and its affiliate Grantchester Equity, Ltd. (“Grantchester”) to obtain a listing on the Vienna Stock Exchange for hempSMART, Ltd., a UK corporation and wholly owned subsidiary of Registrant, through a Luxembourg based holding company; the Company filed Form 8-K on May 3, 2019. On May 1, 2019, the Company mailed a corporate update letter and information sheet to its shareholders; the Company filed Form 8-K on May 1, 2019. On May 14, 2019, the Company signed a Letter of Intent (“LOI”) with Essence Farms, LLC (“Essence”) to form a joint venture (“JV”) called Riverside Hemp Project to operate farming operations in California for the purpose of growing, cultivating, manufacturing, extracting and selling legal hemp and hemp derived CBD. The transaction is pending completion of a material definitive agreement. On May 14, 2019, the Company issued 15,151,515 shares of common stock to St. George Investments, LLC, pursuant to a convertible note payable.

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Interim Financial Statements	Interim Financial Statements The unaudited condensed interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included.
Revenue Recognition	Revenue Recognition The Company recognizes revenue when: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) the selling price is fixed or determinable; and (4) collectability is reasonably assured. Determination of criteria (3) and (4) are based on management’s judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments are provided for in the same period the related revenue is recorded. The Company defers any revenue for which the services has not been performed or is subject to refund until such time that the Company and the customer jointly determine that the services has been performed or no refund will be required.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the fair value of the Company’s stock, stock-based compensation, fair values relating to derivative liabilities, debt discounts and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.
Cash	Cash The Company considers cash to consist of cash on hand and temporary investments having an original maturity of 90 days or less that are readily convertible into cash.
Concentrations of Credit Risk	Concentrations of credit risk The Company’s financial instruments that are exposed to a concentration of credit risk are cash and accounts receivable. Occasionally, the Company’s cash and cash equivalents in interest-bearing accounts may exceed FDIC insurance limits. The financial stability of these institutions is periodically reviewed by senior management.
Accounts Receivable	Accounts Receivable Trade receivables are carried at their estimated collectible amounts. Trade credit is generally extended on a short-term basis; thus, trade receivables do not bear interest. Trade accounts receivable are periodically evaluated for collectability based on past credit history with customers and their current financial condition.
Allowance for Doubtful Accounts	Allowance for Doubtful Accounts Any charges to the allowance for doubtful accounts on accounts receivable are charged to operations in amounts sufficient to maintain the allowance for uncollectible accounts at a level management believes is adequate to cover any probable losses. Management determines the adequacy of the allowance based on historical write-off percentages and the current status of accounts receivable. Accounts receivable are charged off against the allowance when collectability is determined to be permanently impaired. As of March 31, 2019, and December 31, 2018, allowance for doubtful accounts was $0 and $0 respectively.
Inventories	Inventories Inventories are stated at the lower of cost or market with cost being determined on a first-in, first-out (FIFO) basis. The Company writes down its inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. During the periods presented, there were no inventory write-downs.
Cost of Sales	Cost of sales Cost of sales is comprised of cost of product sold, packaging, and shipping costs.
Stock Based Compensation	Stock Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by the Company in the same expense classifications in the statements of operations, as if such amounts were paid in cash.
Earnings per Share	Earnings per Share Basic earnings per share are calculated by dividing net income (loss) by the weighted average number of shares of the Company’s common stock outstanding during the period. “Diluted earnings per share” reflects the potential dilution that could occur if our share-based awards and convertible securities were exercised or converted into common stock. The dilutive effect of our share-based awards is computed using the treasury stock method, which assumes all share-based awards are exercised and the hypothetical proceeds from exercise are used to purchase common stock at the average market price during the period. The incremental shares (difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted EPS calculation. The dilutive effect of our convertible preferred stock and convertible debentures is computed using the if-converted method, which assumes conversion at the beginning of the year. As of March 31, 2019, and 2018, respectively, common stock equivalents relating to convertible debt, warrants and options were not included in the denominators of the diluted earnings per share as their effect would be anti-dilutive.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives of 3 to 5 years.
Investments	Investments The Company follows Accounting Standards Codification subtopic 321-10, Investments-Equity Securities (“ASC 321-10) which requires the accounting for equity security to be measured at fair value with changes in unrealized gains and losses are included in current period operations. Where an equity security is without a readily determinable fair value, the Company may elect to estimate its fair value at cost minus impairment plus or minus changes resulting from observable price changes (See Note 4).
Derivative Financial Instruments	Derivative Financial Instruments The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provide the Company with a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company's own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. The Company’s free-standing derivatives consisted of conversion options embedded within its issued convertible debt and warrants with anti-dilutive (reset) provisions. The Company evaluated these derivatives to assess their proper classification in the balance sheet using the applicable classification criteria enumerated under GAAP. The Company determined that certain conversion and exercise options do not contain fixed settlement provisions. The convertible notes contain a conversion feature and warrants have a reset provision such that the Company could not ensure it would have adequate authorized shares to meet all possible conversion demands. As such, the Company was required to record the conversion feature and the reset provision which does not have fixed settlement provisions as liabilities and mark to market all such derivatives to fair value at the end of each reporting period. The Company has adopted a sequencing policy that reclassifies contracts (from equity to assets or liabilities) with the most recent inception date first. Thus, any available shares are allocated first to contracts with the most recent inception dates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2019 and December 31, 2018. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash and accounts payable. Fair values were assumed to approximate carrying values for cash, accounts payables and short term notes because they are short term in nature.
Advertising	Advertising The Company follows the policy of charging the costs of advertising to expense as incurred. The Company charged to operations $141,339 and $55,745 for the three months ended March 31, 2019 and 2018, respectively, as advertising costs.
Income Taxes	Income Taxes Deferred income tax assets and liabilities are determined based on the estimated future tax effects of net operating loss and credit carry forwards and temporary differences between the tax basis of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The Company records an estimated valuation allowance on its deferred income tax assets if it is not more likely than not that these deferred income tax assets will be realized. The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. As of March 31, 2019, and 2018, the Company has not recorded any unrecognized tax benefits.
Segment Information	Segment Information Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions how to allocate resources and assess performance. The information disclosed herein materially represents all of the financial information related to the Company's only material principal operating segment.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (ASU 2016-02). Under ASU No. 2016-2, an entity is required to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. ASU No. 2016-02 offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. For public companies, The Company adopted this standard on January 1, 2019 using the modified retrospective method. The new standard provides a number of optional practical expedients in transition. The Company elected the ‘package of practical expedients’, which permitted the Company not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs; and all of the new standard's available transition practical expedients.
Subsequent Events	Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed.

Property And Equipment (Tables)

Property And Equipment (Tables)	3 Months Ended
	Mar. 31, 2019
Property And Equipment
Schedule of Property and Equipment	Property and equipment as of March 31, 2019 and December 31, 2018 is summarized as follows: March 31, 2019 December 31, 2018 Computer equipment $ 17,438 $ 15,207 Furniture and fixtures 5,140 5,140 Subtotal 22,578 20,347 Less accumulated depreciation (9,512 ) (7,917 ) Property and equipment, net $ 13,066 $ 12,430

Convertible Note Payable (Table

Convertible Note Payable (Tables)	3 Months Ended
	Mar. 31, 2019
Disclosure Convertible Note Payable Tables Abstract
Schedule of Convertible Notes Payable	Convertible notes payable are comprised of the following: March 31, 2019 December 31, 2018 Convertible note payable-John Fife, last due October 27, 2018 $ — $ 150,959 Convertible notes payable-St George-last due January 24, 2020 2,927,889 1,877,890 Total 2,927,889 2,028,849 Less debt discounts (1,391,618 ) (896,180 ) Net 1,536,271 1,132,669 Less current portion 1,536,271 (1,132,669 ) Long term portion $ — $ —

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	3 Months Ended
	Mar. 31, 2019
Disclosure Stockholders Deficit Tables Abstract
Summarizes the Stock Option Activity	The following table summarizes the stock option activity for the three months ended March 31, 2019: Shares Weighted-Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at December 31, 2018 1,000,000,000 $ 0.005 6.76 $ 10,100,000 Granted — — — — Cancellations (1,000,000,000 ) 0.005 6.76 — Forfeitures or expirations — — — — Outstanding at March 31, 2019 — $ — — $ — Exercisable at March 31, 2019 — $ — — $ —
Schedule of Options by Excerise Price Range	The following table presents information related to stock options at March 31, 2019: Options Outstanding Options Exercisable Exercise Price Number of Options Weighted Average Remaining Life In Years Exercisable Number of Options $ — — — —
Summarizes the Stock Warrant Activity	The following table summarizes the stock warrant activity for the three months ended March 31, 2019: Shares Weighted-Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2019 110,846,817 $ 0.039 4.18 $ 25,500 Granted 115,166,666 0.020 4.87 267 Exercised (11,551,252 ) 0.020 2.55 20,400 Outstanding at March 31, 2019 214,462,231 $ 0.040 4.44 $ 5,367 Exercisable at March 31, 2019 214,462,231 $ 0.040 4.44 $ 5,367
Schedule of Warrants by Excerise Price Range	The following table presents information related to warrants at March 31, 2019: Warrants Outstanding Warrants Exercisable Exercise Price Number of Warrants Weighted Average Remaining Life In Years Exercisable Number of Warrants $ 0.04 214,462,231 4.44 214,462,231
Summarizes the Restricted Stock Activity	The following table summarizes the restricted stock activity for the three months ended March 31, 2019: Total Restricted Shares Issued at January 1, 2019 10,000,000 Granted — Forfeited — Total Restricted Shares Issued at March 31, 2019 10,000,000 Vested at March 31, 2019 10,000,000

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended
	Mar. 31, 2019
Disclosure Derivative Liabilities Tables Abstract
Summary of Changes in Fair Value of Derivative Liabilities	The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the three years ended March 31, 2019: Debt Derivative Balance, January 1, 2019 $ 2,256,631 Total (gains) losses Initial fair value of debt derivative at note issuance 278,376 Mark-to-market at March 31, 2019: 2,687,449 Transfers out of Level 3 upon conversion or payoff of notes payable (260,790 ) Balance, March 31, 2019 $ 4,961,666 Net gain for the period included in earnings relating to the liabilities held during the period ended March 31, 2019 $ 2,723,792

Property And Equipment (Details

Property And Equipment (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 22,578	$ 20,347
Less accumulated depreciation	9,512	7,917
Property and equipment, net	13,066	12,430
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	17,438	15,207
Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 5,140	$ 5,140

Convertible Note Payable (Detai

Convertible Note Payable (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Short-term Debt [Line Items]
Total	$ 2,927,889	$ 2,028,849
Less debt discounts	(1,391,618)	(896,180)
Net	1,536,271	1,132,669
Less current portion	1,536,271	1,132,669
Long term portion
Convertible Notes Payable - John Fife - Last Due October 27, 2018 [Member]
Short-term Debt [Line Items]
Total		150,959
Convertible Notes Payable-St George - Last Due January 24, 2020 [Member]
Short-term Debt [Line Items]
Total	$ 2,927,889	$ 1,877,890

Stockholders' Deficit (Summariz

Stockholders' Deficit (Summarizes The Stock Option Activity) (Details)	3 Months Ended
	Mar. 31, 2019USD ($)$ / sharesshares
Shares
Outstanding at Beginning of Period | shares	1,000,000,000
Granted | shares
Cancellations | shares	(1,000,000,000)
Forfeitures or expirations | shares
Outstanding at End of Period | shares
Exercisable at End of Period | shares
Weighted-Average Exercise Price
Outstanding at Beginning of Period | $ / shares	$ 0.005
Granted | $ / shares
Cancellations | $ / shares	0.005
Forfeitures or expirations | $ / shares
Outstanding at End of Period | $ / shares
Exercisable at End of Period | $ / shares
Weighted Average Remaining Contractual Term
Outstanding at Beginning of Period	6 years 9 months 4 days
Cancellations	6 years 9 months 4 days
Outstanding at End of Period
Aggregate Intrinsic Value
Outstanding at Beginning of Period | $	$ 10,100,000

Stockholders' Deficit (Summar_2

Stockholders' Deficit (Summarizes The Stock Warrant Activity) (Details) - Warrants [Member]	3 Months Ended
	Mar. 31, 2019USD ($)$ / sharesshares
Shares
Outstanding at Beginning of Period | shares	110,846,817
Granted | shares	115,166,666
Exercised | shares	(11,551,252)
Outstanding at End of Period | shares	214,462,231
Exercisable at End of Period | shares	214,462,231
Weighted Average Exercise Price
Outstanding at Beginning of Period | $ / shares	$ 0.039
Granted | $ / shares	0.020
Exercised | $ / shares	0.020
Outstanding at End of Period | $ / shares	0.040
Exercisable at End of Period | $ / shares	$ 0.040
Weighted Average Remaining Contractual Term
Outstanding at Beginning of Period	4 years 2 months 5 days
Granted	4 years 10 months 13 days
Exercised	2 years 6 months 18 days
Outstanding at End of Period	4 years 5 months 8 days
Exercisable at End of Period	4 years 5 months 8 days
Aggregate Intrinsic Value
Outstanding at Beginning of Period | $	$ 25,500
Granted | $	267
Exercised | $	20,400
Outstanding at End of Period | $	5,367
Exercisable at End of Period | $	$ 5,367

Stockholders' Deficit (Schedule

Stockholders' Deficit (Schedule Of Warrants By Excerise Price Range) (Details) - Warrants [Member] - Exercise Price Per Share $0.04 [Member]	3 Months Ended
	Mar. 31, 2019$ / sharesshares
Warrants Outstanding
Exercise Price | $ / shares	$ 0.04
Number of Options	214,462,231
Warrants Exercisable
Weighted Average Remaining Life In Years	4 years 5 months 8 days
Exercisable Number of Options	214,462,231

Stockholders' Deficit (Summar_3

Stockholders' Deficit (Summarizes The Restricted Stock Activity) (Details) - Restricted Stock Units [Member]	3 Months Ended
	Mar. 31, 2019shares
Outstanding at Beginning of Period	10,000,000
Granted
Forfeited
Outstanding at End of Period	10,000,000
Vested at End of Period	10,000,000

Fair Value Measurement (Details

Fair Value Measurement (Details)	3 Months Ended
	Mar. 31, 2019USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, at Beginnig of Period	$ 2,256,631
Total (gains) losses
Balance, March 31, 2019	4,961,666
Debt Derivative [Member] | Level 3 Financial Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance, at Beginnig of Period	2,256,631
Total (gains) losses
Initial fair value of debt derivative at note issuance	278,376
Mark-to-market at End of Period	2,687,449
Transfers out of Level 3 upon conversion or payoff of notes payable or cancellation of warrants	(260,790)
Balance, March 31, 2019	4,961,666
Net gain for the period included in earnings relating to the liabilities held during the period ended March 31, 2019	$ 2,723,792

Nature Of Operations And Basi_2

Nature Of Operations And Basis Of Presentation (Narrative) (Details)	1 Months Ended
	Oct. 31, 2009
Sparrowtech, Inc. [Member]
Noncash or Part Noncash Acquisitions [Line Items]
Merger description of Sparrowtech, Inc	In October 2009, in a 30 for 1 exchange, the Company merged with Sparrowtech, Inc. for the purpose of exploration and development of commercially viable mining properties.

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Allowance for doubtful accounts	$ 0		$ 0
Advertising cost	$ 141,339	$ 55,745
Property And Equipment [Member]
Depreciation calculation method	Straight-line method
Property And Equipment [Member] | Minimum [Member]
Estimatied useful lives	3 years
Property And Equipment [Member] | Maximum [Member]
Estimatied useful lives	5 years

Investments (Narrative) (Detail

Investments (Narrative) (Details) - USD ($)	May 30, 2018	May 08, 2018	Aug. 31, 2017	Jun. 16, 2017	Mar. 13, 2017	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Summary of Investment Holdings [Line Items]
Short-term investments						$ 675,000	$ 810,000
Loan Agreement With Convenient Hemp Mart, LLC ("Benihemp") [Member]
Summary of Investment Holdings [Line Items]
Investment description				On June 16, 2017, the Company entered into a Loan Agreement (“Agreement”) with Conveniant Hemp Mart, LLC (“Benihemp”), a limited liability company formed and operating under the laws of the State of Wyoming. Pursuant to the Agreement, Benilhemp executed a promissory note for a principal loan amount of $50,000, accruing interest at the rate of 4% per annum and payable in one year, subject to one-time six- month repayment extension. The Agreement also provided that the Company shall have the option to waive repayment of the note and pay Benihemp an additional $50,000 payment in exchange for a 25% membership interest in Benihemp’s limited liability company.
Investment, value				$ 50,000
Investment interest rate				4.00%
Stock Purchase Agreement With MoneyTrac Technology, Inc., [Member]
Summary of Investment Holdings [Line Items]
Investment description					On March 13, 2017, the Company entered into a stock purchase agreement to acquire up to 15,000,000 common shares of MoneyTrac Technology, Inc., a corporation organized and operating under the laws of the state of California, for a total purchase price of $250,000 representing approximately 15% ownership at the time of the agreement.
Investment, shares								15,000,000
Investment, value								$ 250,000
Percentage of investment ownership								15.00%
Merge Of MoneyTrac Into GlobalPayout For Shares Exchange [Member]
Summary of Investment Holdings [Line Items]
Short-term investments						$ 675,000	$ 810,000
Joint Venture Agreement With Global Hemp Group, Inc. [Member]
Summary of Investment Holdings [Line Items]
Investment description			On August 31, 2017, the Company entered into a Joint Venture Agreement (“Agreement”) with Global Hemp Group, Inc., a Canadian corporation (“Global Hemp Group”). The Company will assist Global Hemp Group in developing commercial hemp production in New Brunswick, Canada. In the first year of the Agreement, the Company will share the costs of the ongoing hemp trial in New Brunswick; provide its expertise in developing hemp cultivation going forward; and, be granted a right of first refusal as Global Hemp Group’s primary off-taker of any raw materials produced from the project. The Company’s joint venture partner, Global Hemp Group, also partnered with Collège Communautaire du Nouveau Brunswick (CCNB) in Bathurst, New Brunswick, to assist in conducting research with the hemp trials. The trials are taking place on the Acadian peninsula of New Brunswick, and the initial trials to establish commercial cultivation pursuant to the Agreement are expected to be completed during 2019.
Joint Venture Agreement With Global Hemp Group JV/Scio, Oregon [Member] | Global Hemp Group, Inc - A Company Related By Charles Larsen, Director Of The Company [Member]
Summary of Investment Holdings [Line Items]
Investment description	. On May 30, 2018, the joint venture purchased TTO’s 15% interest in the joint venture for $30,000. The Company and Global Hemp Group, Inc. now have an equal 50-50 interest in the joint venture. The joint venture agreement commits the Company to a cash contribution of $600,000 payable on the following funding schedule: $200,000 upon execution of the joint venture agreement; $238,780 by July 31, 2018; $126,445 by October 31, 2018; and, $34,775 by January 31, 2019. The Company has complied with its payments.	On May 8, 2018, the Company, Global Hemp Group, Inc., a Canadian corporation, and TTO Enterprises, Ltd., an Oregon corporation entered into a Joint Venture Agreement. The purpose of the joint venture is to develop a project to commercialize the cultivation of industrial hemp on a 109 acre parcel of real property owned by the Company and Global Hemp Group in Scio, Oregon, and operating under the Oregon corporation Covered Bridges, Ltd. The joint venture is in the development stage.
Total committed amount to raise for joint ventures	$ 600,000

Notes Payable, Related Party (N

Notes Payable, Related Party (Narrative) (Details) - Officers And Directors [Member] - Notes Payable [Member]	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Short-term Debt [Line Items]
Notes payable description	The issued notes are unsecured, due on demand	The issued notes are unsecured, due on demand
Notes payable interest rate	5.00%	5.00%

Convertible Note Payable (Narra

Convertible Note Payable (Narrative) (Details1) - USD ($)	Dec. 31, 2017	Dec. 20, 2017	Nov. 11, 2017	Nov. 01, 2017	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Short-term Debt [Line Items]
Net proceeds from convertible promissory notes					$ 649,575	$ 400,000
Convertible notes payable					$ 1,536,271		$ 1,132,669
Common Stock [Member]
Short-term Debt [Line Items]
Shares issued for settlement of debt, shares						16,637,073
Warrants [Member]
Short-term Debt [Line Items]
Warrants issued for debt as an investment incentive					115,166,666
Secured Convertible Promissory Notes Dated November 01, 2017 - St George Investments [Member]
Short-term Debt [Line Items]
Convertible promissory note face value				$ 601,420
Convertible promissory note interest rate				10.00%
Convertible promissory note due date description				It is due upon maturity sixteen months after purchase price date
Convertible promissory note original interest discount				$ 59,220
Net proceeds from convertible promissory notes			$ 542,200
Convertible notes payable					$ 417,890
Convertible promissory note conversion terms				The promissory notes are convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price.
Convertible promissory note payment terms				The Company has a right to prepayment of the note, subject to a 20% prepayment premium and is secured by a trust deed of certain assets of the Company.
Secured Convertible Promissory Notes Dated December 20, 2017 - St George Investments [Member]
Short-term Debt [Line Items]
Convertible promissory note face value		$ 1,655,000
Convertible promissory note interest rate		10.00%
Convertible promissory note due date description		It is due upon maturity sixteen months after purchase price date
Convertible promissory note original interest discount		$ 155,000
Net proceeds from convertible promissory notes	$ 300,000
Legal fees for convertible promissory note		$ 5,000
Convertible promissory note description		The promissory note was funded in nine tranches of $300,000; $200,000; $200,000; $400,000; $75,000; $150,000; $85,000; $120,000 and $70,000, resulting in receiving aggregate net proceeds of $1,500,000 under this note.
Convertible promissory note conversion terms		The promissory notes are convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price.
Convertible promissory note payment terms		The Company has a right to prepayment of the note, subject to a 20% prepayment premium and is secured by a trust deed of certain assets of the Company.
Secured Convertible Promissory Notes Dated December 20, 2017 - St George Investments [Member] | Warrants [Member]
Short-term Debt [Line Items]
Warrants issued for debt as an investment incentive		66,000,000
Cashless warrant period		5 years
Exercisable price		$ 0.04
Secured Convertible Promissory Notes - St George Investments [Member] | Common Stock [Member]
Short-term Debt [Line Items]
Shares issued for settlement of debt, value					220,000
Derivative liabilities portion of debt converted into common stock					$ 100,336
Shares issued for settlement of debt, shares					31,151,515

Convertible Note Payable (Nar_2

Convertible Note Payable (Narrative) (Details2) - USD ($)	Mar. 25, 2019	Mar. 21, 2019	Jan. 29, 2019	Nov. 05, 2018	Aug. 28, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Short-term Debt [Line Items]
Net proceeds from convertible promissory notes						$ 649,575	$ 400,000
Warrants [Member]
Short-term Debt [Line Items]
Warrants issued for debt as an investment incentive						115,166,666
Secured Convertible Promissory Notes - St George Investments [Member]
Short-term Debt [Line Items]
Note assigned from St.George				$ 250,000
Secured Convertible Promissory Notes Assigned To John Fife [Member]
Short-term Debt [Line Items]
Shares issued for settlement of debt, value		$ 150,959
Accrued interest portion of debt converted into common stock		$ 4,963
Shares issued for settlement of debt, shares		23,667,574
Secured Convertible Promissory Notes August 28, 2018 - St George Investments [Member]
Short-term Debt [Line Items]
Convertible promissory note face value					$ 1,105,000
Convertible promissory note interest rate					10.00%
Convertible promissory note due date description					It is due upon maturity ten months after purchase price date.
Convertible promissory note original interest discount					$ 100,000
Legal fees for convertible promissory note					$ 5,000
Net proceeds from convertible promissory notes						$ 125,000		$ 825,000
Convertible promissory note conversion terms					The promissory note is convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price.
Convertible promissory note payment terms					The Company has a right to prepayment of the note, subject to a 15% prepayment premium and is secured by a trust deed of certain assets of the Company.
Additional proceeds from convertible promissory note						135,000
Fair value of issued warrants						1,588,493
Face value of funding percentage						1,105,000
Fair value of embedded derivatives						$ 1,180,646
Fair value of assumption model						Binomial Option Pricing Model
Dividend yield						0.00%
Expected volatility						112.40%
Weighted average risk-free interest rate						2.54%
Expected life						5 months 23 days
Estimated fair value of common stock						$ 0.18
Reduction of interest expenses						$ 36,343
Secured Convertible Promissory Notes August 28, 2018 - St George Investments [Member] | Warrants [Member]
Short-term Debt [Line Items]
Warrants issued for debt as an investment incentive					45,000,000
Cashless warrant period					5 years
Exercisable price					$ 0.04
Secured Convertible Promissory Notes January 29, 2019 - St George Investments [Member]
Short-term Debt [Line Items]
Convertible promissory note face value			$ 2,205,000
Convertible promissory note interest rate			10.00%
Convertible promissory note due date description			It is due upon maturity ten months after purchase price date.
Convertible promissory note original interest discount			$ 200,000
Legal fees for convertible promissory note			$ 5,000
Net proceeds from convertible promissory notes						500,000
Convertible promissory note conversion terms			The promissory note is convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price.
Convertible promissory note payment terms			The Company has a right to prepayment of the note, subject to a 15% prepayment premium and is secured by a trust deed of certain assets of the Company.
Fair value of embedded derivatives			$ 999,838			$ 44,898
Fair value of assumption model			Binomial Option Pricing Model			Binomial Option Pricing Model
Dividend yield			0.00%			0.00%
Expected volatility			109.63%			107.91%
Weighted average risk-free interest rate			2.55%
Expected life			5 years
Estimated fair value of common stock			$ 0.0162
Convertible promissory note description			The promissory note was funded in three tranches totaling $555,000 resulting in receiving aggregate net proceeds of $500,000 under this note. The net proceeds received consisted of $393,780 in cash and $161,220 in payments on behalf of the Company.
Proceeds allocated to warrants						$ 167,225
Secured Convertible Promissory Notes January 29, 2019 - St George Investments [Member] | Minimum [Member]
Short-term Debt [Line Items]
Weighted average risk-free interest rate						2.31%
Expected life						9 months
Estimated fair value of common stock						$ .0132
Secured Convertible Promissory Notes January 29, 2019 - St George Investments [Member] | Maximum [Member]
Short-term Debt [Line Items]
Weighted average risk-free interest rate						2.50%
Expected life						10 months
Estimated fair value of common stock						$ .0163
Secured Convertible Promissory Notes January 29, 2019 - St George Investments [Member] | Warrants [Member]
Short-term Debt [Line Items]
Warrants issued for debt as an investment incentive			90,000,000
Cashless warrant period			5 years
Exercisable price			$ 0.04
Secured Convertible Promissory Notes March 25, 2019 - St George Investments [Member]
Short-term Debt [Line Items]
Convertible promissory note face value	$ 580,000
Convertible promissory note interest rate	10.00%
Convertible promissory note due date description	It is due upon maturity ten months after purchase price date.
Convertible promissory note original interest discount	$ 75,000
Legal fees for convertible promissory note	$ 5,000
Net proceeds from convertible promissory notes						$ 500,000
Convertible promissory note conversion terms	The promissory note is convertible, at any time at the lender’s option, at $0.04. However, in the event the Company’s market capitalization (as defined) falls below $30,000,000, the conversion rate is 60% of the 3 lowest closing trade prices due the 20 trading days immediately preceding date of conversion, subject to additional adjustments, as defined. In addition, the promissory note includes certain anti-dilution provisions should the Company subsequently issue any common stock or equivalents at an effective price less than the lender conversion price.
Convertible promissory note payment terms	The Company has a right to prepayment of the note, subject to a 15% prepayment premium and is secured by a trust deed of certain assets of the Company.
Fair value of embedded derivatives	$ 258,701					$ 233,477
Fair value of assumption model	Binomial Option Pricing Model					Binomial Option Pricing Model
Dividend yield	0.00%					0.00%
Expected volatility	108.20%					108.85%
Weighted average risk-free interest rate	2.21%					2.48%
Expected life	5 years					10 days
Estimated fair value of common stock	$ 0.0169					$ 0.0169
Convertible promissory note description	The promissory note was funded in the amount of $580,000 resulting in receiving aggregate net proceeds of $500,000 under this note.
Proceeds allocated to warrants						$ 170,489
Secured Convertible Promissory Notes March 25, 2019 - St George Investments [Member] | Warrants [Member]
Short-term Debt [Line Items]
Warrants issued for debt as an investment incentive	22,500,000
Cashless warrant period	5 years
Exercisable price	$ 0.04

Convertible Note Payable (Nar_3

Convertible Note Payable (Narrative) (Details3) - USD ($)	Mar. 31, 2019	Mar. 31, 2019	Mar. 31, 2018
Short-term Debt [Line Items]
Gain (loss) on change in fair value of derivative liabilities		$ (2,687,449)	$ 5,056,686
Amortization of debt discount		495,438	$ 502,682
Convertible Promissory Notes [Member]
Short-term Debt [Line Items]
Gain (loss) on change in fair value of derivative liabilities		2,687,449
Convertible Promissory Notes [Member] | Interest Expense [Member]
Short-term Debt [Line Items]
Amortization of debt discount		463,282
Debt Derivative [Member]
Short-term Debt [Line Items]
Fair value of embedded derivatives	$ 4,961,666	$ 4,961,666
Fair value of assumption model	Binomial Option Pricing Model
Dividend yield	0.00%
Expected volatility	107.54%
Weighted average risk-free interest rate	2.40%
Estimated fair value of common stock	$ 0.0151	$ 0.0151
Debt Derivative [Member] | Minimum [Member]
Short-term Debt [Line Items]
Expected life	3 years
Debt Derivative [Member] | Maximum [Member]
Short-term Debt [Line Items]
Expected life	9 months 24 days

Stockholders' Deficit (Narrativ

Stockholders' Deficit (Narrative) (Details) - $ / shares	Mar. 31, 2019	Feb. 27, 2019	Mar. 31, 2019
Cancelled shares			(1,000,000,000)
Warrants [Member]
Intrinsic value descriptions	Based on options with an exercise price less than the Company’s stock price of $0.0151
Warrants or stock unit granted during the period			115,166,666
Convertible Promissory Notes [Member] | Warrants [Member]
Warrants or stock unit granted during the period			112,500,000
Exercisable price	$ 0.04		$ 0.04
Warrants expiration period			5 years
Common Stock [Member] | Donald Steinberg - Chief Executive Officer [Member] | Stock Option [Member]
Cancelled shares		1,000,000,000
Class A Preferred Stock [Member]
Preferred stock voting rights			Each share of Class A Preferred Stock is entitled to 100 votes on all matters submitted to a vote to the stockholders of the Company
Preferred stock conversion terms			Preferred stock does not have conversion.

Fair Value Measurement (Narrati

Fair Value Measurement (Narrative) (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Level 3 Financial Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Combined derivative and warrant liability	$ 4,961,666	$ 2,256,631

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Related Party Transaction [Line Items]
Accrued compensation	$ 442,659	$ 454,316
Notes payable	396,781	287,140
Officers And Executives [Member]
Related Party Transaction [Line Items]
Accrued compensation	442,659	454,316
Officers [Member] | Notes Payable [Member]
Related Party Transaction [Line Items]
Notes payable	$ 396,781	$ 287,140
Notes payable interest rate	5.00%	5.00%
Notes payable description	The note is non-interest bearing, respectively, and are due on demand.	The note is non-interest bearing, respectively, and are due on demand.

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details)	May 14, 2019shares
Subsequent Event [Member] | Secured Convertible Promissory Notes - St George Investments [Member]
Subsequent Event [Line Items]
Shares issued for convertible notes payable	15,151,515